Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 15 de 15
1.
Brain Res ; 1602: 96-105, 2015 Mar 30.
Article En | MEDLINE | ID: mdl-25617821

The dorsal periaqueductal gray area (dPAG) is involved in cardiovascular modulation. In a previous study, we showed that noradrenaline (NA) microinjected into the dPAG caused a vasopressin-mediated pressor response, involving a relay in the hypothalamic paraventricular nucleus (PVN). In the present study, we evaluated the involvement of ionotropic glutamate receptors within the PVN in the cardiovascular response to NA microinjection into the dPAG of unanesthetized rats. Microinjection of the selective NMDA glutamate receptor antagonist LY235959 (2nmol/100nL) unilaterally into the PVN did not affect the cardiovascular response evoked by microinjection of NA (15nmol/50nL) into the dPAG. On the other hand, unilateral PVN pretreatment with the non-NMDA glutamate receptor antagonist NBQX (2nmol/100nL) significantly reduced the pressor and cardiac response caused by microinjection of NA into the dPAG. In addition, bilateral PVN pretreatment with NBQX (2nmol/100nL) blocked the cardiovascular response to NA injected into the dPAG. In conclusion, the present results suggest that bilateral PVN activation of non-NMDA glutamate receptors mediates the vasopressin-related cardiovascular response to the microinjection of NA into the dPAG.


Blood Pressure/physiology , Heart Rate/physiology , Norepinephrine/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , Periaqueductal Gray/metabolism , Adrenergic alpha-Agonists/administration & dosage , Animals , Blood Pressure/drug effects , Bradycardia/metabolism , Catheters, Indwelling , Excitatory Amino Acid Antagonists/pharmacology , Heart Rate/drug effects , Isoquinolines/pharmacology , Male , Microinjections , Norepinephrine/administration & dosage , Paraventricular Hypothalamic Nucleus/drug effects , Periaqueductal Gray/drug effects , Quinoxalines/pharmacology , Rats, Wistar , Receptors, AMPA/antagonists & inhibitors , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/metabolism
2.
Stress ; 17(4): 362-72, 2014 Jul.
Article En | MEDLINE | ID: mdl-24903268

Restraint stress (RS) is an experimental model to study stress-related cardiovascular responses, characterized by sustained pressor and tachycardiac responses. We used pharmacologic and surgical procedures to investigate the role played by sympathetic nervous system (SNS) and parasympathetic nervous system (PSNS) in the mediation of stress-evoked cardiovascular responses. Ganglionic blockade with pentolinium significantly reduced RS-evoked pressor and tachycardiac responses. Intravenous treatment with homatropine methyl bromide did not affect the pressor response but increased tachycardia. Pretreatment with prazosin reduced the pressor and increased the tachycardiac response. Pretreatment with atenolol did not affect the pressor response but reduced tachycardia. The combined treatment with atenolol and prazosin reduced both pressor and tachycardiac responses. Adrenal demedullation reduced the pressor response without affecting tachycardia. Sinoaortic denervation increased pressor and tachycardiac responses. The results indicate that: (1) the RS-evoked cardiovascular response is mediated by the autonomic nervous system without an important involvement of humoral factors; (2) hypertension results primarily from sympathovascular and sympathoadrenal activation, without a significant involvement of the cardiac sympathetic component (CSNS); (3) the abrupt initial peak in the hypertensive response to restraint is sympathovascular-mediated, whereas the less intense but sustained hypertensive response observed throughout the remaining restraint session is mainly mediated by sympathoadrenal activation and epinephrine release; (4) tachycardia results from CSNS activation, and not from PSNS inhibition; (5) RS evokes simultaneous CSNS and PSNS activation, and heart rate changes are a vector of both influences; (6) the baroreflex is functional during restraint, and modulates both the vascular and cardiac responses to restraint.


Atenolol/pharmacology , Autonomic Nervous System/drug effects , Baroreflex/drug effects , Cardiovascular System/drug effects , Stress, Psychological/physiopathology , Animals , Blood Pressure/physiology , Disease Models, Animal , Heart Rate/drug effects , Heart Rate/physiology , Male , Rats, Wistar , Restraint, Physical
3.
J Neurosci Res ; 90(11): 2193-200, 2012 Nov.
Article En | MEDLINE | ID: mdl-22715034

The periaqueductal gray area (PAG) is a mesencephalic area involved in cardiovascular modulation. Glutamate (L-Glu) is an abundant excitatory amino acid in the central nervous system (CNS) and is present in the rat PAG. Moreover, data in the literature indicate its involvement in central blood pressure control. Here we report on the cardiovascular effects caused by microinjection of L-Glu into the dorsomedial PAG (dmPAG) of rats and the glutamatergic receptors as well as the peripheral mechanism involved in their mediation. The microinjection of L-Glu into the dmPAG of unanesthetized rats evoked dose-related pressor and bradycardiac responses. The cardiovascular response was significantly reduced by pretreatment of the dmPAG with a glutamatergic M-methyl-D-aspartate (NMDA) receptor antagonist (LY235959) and was not affected by pretreatment with a non-NMDA receptor antagonist (NBQX), suggesting a mediation of that response by the activation of NMDA receptors. Furthermore, the pressor response was blocked by pretreatment with the ganglion blocker pentolinium (5 mg/kg, intravenously), suggesting an involvement of the sympathetic nervous system in this response. Our results indicate that the microinjection of L-Glu into the dmPAG causes sympathetic-mediated pressor responses in unanesthetized rats, which are mediated by glutamatergic NMDA receptors in the dmPAG.


Cardiovascular System/drug effects , Glutamic Acid/administration & dosage , Periaqueductal Gray/drug effects , Animals , Blood Pressure/drug effects , Dose-Response Relationship, Drug , Heart Rate/drug effects , Male , Microinjections , Rats , Rats, Wistar
4.
Life Sci ; 84(13-14): 444-50, 2009 Mar 27.
Article En | MEDLINE | ID: mdl-19302815

AIMS: The dorsal periaqueductal gray area (dPAG) is involved in cardiovascular modulation. Previously, we reported that noradrenaline (NA) microinjection into the dPAG caused a pressor response that was mediated by vasopressin release into the circulation. However, the neuronal pathway that mediates this response is as yet unknown. There is evidence that chemical stimulation of the diagonal band of Broca (dbB) also causes a pressor response mediated by systemic vasopressin release. In the present study, we evaluated the participation of the dbB in the pressor response caused by NA microinjection into the dPAG as well as the existence of neural connections between these areas. MAIN METHODS: With the above goal, we verified the effect of the pharmacological ablation of the dbB on the cardiovascular response to NA microinjection into the dPAG of unanesthetized rats. In addition, we microinjected the neuronal tracer biotinylated-dextran-amine (BDA) into the dPAG and looked for efferent projections from the dPAG to the dbB. KEY FINDINGS: The pharmacologically reversible ablation of the dbB with local microinjection of CoCl(2) significantly reduced the pressor response caused by NA microinjection (15 nmol/50 nL) into the dPAG. In addition, BDA microinjection into the dPAG labeled axons in the dbB, pointing to the existence of direct connections between these areas. SIGNIFICANCE: The present results indicate that synapses within the dbB are involved in the pressor pathway activated by NA microinjection into the dPAG and direct neural projection from the dPAG to the dbB may constitute the neuroanatomic substrate for this pressor pathway.


Blood Pressure/drug effects , Diagonal Band of Broca/drug effects , Norepinephrine/pharmacology , Periaqueductal Gray/drug effects , Animals , Biotin/analogs & derivatives , Biotin/pharmacology , Blood Pressure/physiology , Brain Mapping , Cobalt/pharmacology , Dextrans/pharmacology , Diagonal Band of Broca/physiology , Efferent Pathways/drug effects , Efferent Pathways/physiology , Heart Rate/drug effects , Heart Rate/physiology , Male , Microinjections , Norepinephrine/administration & dosage , Periaqueductal Gray/physiology , Rats , Rats, Wistar , Synapses/drug effects , Synapses/physiology
5.
Auton Neurosci ; 147(1-2): 38-47, 2009 May 11.
Article En | MEDLINE | ID: mdl-19185547

The medial prefrontal cortex (MPFC) is involved in cardiovascular control. MPFC electrical stimulation has been reported to cause depressor and bradycardic responses in anesthetized rats. Although the pathway involved is yet unknown, there is evidence indicating the existence of a relay in the lateral hypothalamus (LH). The medial forebrain bundle (MFB) that courses in the lateral portion of the LH carries the vast majority of telencephalic afferent as well efferent projections, including those from the MPFC. To evaluate if the hypotensive pathway originating in the MPFC courses the MFB, we studied the effect of coronal or sagittal knife cuts through the LH and other brain areas on the cardiovascular responses to MPFC electrical stimulation. Knife cuts were performed using blades 1 to 6 mm wide. Results indicate that the neural pathway descending from the MFB decussates early in the vicinity of MPFC, crossing the midline within the corpus callosum and yielding two descending pathways that travel rostro-caudally in the lateral portion of the LH, within the MFB. The decussation was confirmed by histological analysis of brain sections processed after the injection of biotinilated dextran amine in the site of the stimulation in the MPFC. Because knife cuts through the LH ipsilateral had minimal effects on the cardiovascular responses and knife cuts performed contralateral to the stimulated MPFC had no effect on the response to MPFC stimulation, data indicate that the contralateral limb of the pathway may be only activated as an alternative pathway when the ipsilateral pathway is blocked.


Autonomic Pathways/physiology , Cardiovascular Physiological Phenomena , Diencephalon/physiology , Medial Forebrain Bundle/physiology , Prefrontal Cortex/physiology , Animals , Autonomic Pathways/anatomy & histology , Biotin/analogs & derivatives , Brain Mapping , Denervation , Dextrans , Diencephalon/anatomy & histology , Efferent Pathways/anatomy & histology , Efferent Pathways/physiology , Electric Stimulation , Functional Laterality/physiology , Hypothalamic Area, Lateral/anatomy & histology , Hypothalamic Area, Lateral/physiology , Male , Medial Forebrain Bundle/anatomy & histology , Prefrontal Cortex/anatomy & histology , Rats , Rats, Wistar , Staining and Labeling
6.
Auton Neurosci ; 145(1-2): 63-70, 2009 Jan 28.
Article En | MEDLINE | ID: mdl-19059010

We report on the cardiovascular effects of noradrenaline (NA) microinjection into the hypothalamic supraoptic nucleus (SON) as well as the central and peripheral mechanisms involved in their mediation. Microinjections of NA 1, 3, 10, 30 or 45 nmol/100 nL into the SON caused dose-related pressor and bradycardiac response in unanesthetized rats. The response to NA 10 nmol was blocked by SON pretreatment with 15 nmol of the alpha(2)-adrenoceptor antagonist RX821002 and not affected by pretreatment with equimolar dose of the selective alpha(1)-adrenoceptor antagonist WB4101, suggesting that local alpha(2)-adrenoceptors mediate these responses. Pretreatment of the SON with the nonselective beta-adrenoceptor antagonist propranolol 15 nmol did not affect the pressor response to NA microinjection of into the SON. Moreover, the microinjection of the 100 nmol of the selective alpha(1)-adrenoceptor agonist methoxamine (MET) into the SON did not cause cardiovascular response while the microinjection of the selective alpha(2)-adrenoceptor agonists BHT920 (BHT, 100 nmol) or clonidine (CLO, 5 nmol) caused pressor and bradycardiac responses, similar to that observed after the microinjection of NA. The pressor response to NA was potentiated by intravenous pretreatment with the ganglion blocker pentolinium and was blocked by intravenous pretreatment with the V(1)-vasopressin receptor antagonist dTyr(CH2)5(Me)AVP, suggesting an involvement of circulating vasopressin in this response. In conclusion, our results suggest that pressor responses caused by microinjections of NA into the SON involve activation of local alpha(2)-adrenoceptor receptors and are mediated by vasopressin release into circulation.


Microinjections/methods , Norepinephrine/administration & dosage , Pressoreceptors/drug effects , Supraoptic Nucleus/drug effects , Wakefulness/drug effects , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Dose-Response Relationship, Drug , Male , Pressoreceptors/physiology , Rats , Rats, Wistar , Supraoptic Nucleus/physiology , Wakefulness/physiology
7.
Stress ; 12(2): 178-85, 2009 Mar.
Article En | MEDLINE | ID: mdl-18609300

The paraventricular nucleus of the hypothalamus (PVN) has been implicated in several aspects of cardiovascular control. Stimulation of the PVN evokes changes in blood pressure and heart rate. Additionally, this brain area is connected to several limbic structures implicated in behavioral control, as well as to forebrain and brainstem structures involved in cardiovascular control. This evidence indicates that the PVN may modulate cardiovascular correlates of behavioral responses to stressful stimuli. Acute restraint is an unavoidable stressor that evokes marked and sustained cardiovascular changes, which are characterized by elevated mean arterial pressure (MAP) and an intense heart rate (HR) increase. We report on the effect of inhibition of PVN synapses on MAP and HR responses evoked by acute restraint in rats. Bilateral microinjection of the nonspecific synaptic blocker cobalt (CoCl(2), 1 mM/100 nl) into the PVN did not change the HR response or the initial peak of the MAP response to restraint stress, but reduced the area under the curve of the MAP response. Moreover, bilateral microinjection of cobalt in areas surrounding the PVN did not change the cardiovascular response to restraint. These results indicate that synapses in the PVN are involved in the neural pathway that controls blood pressure changes evoked by restraint.


Cardiovascular System/physiopathology , Paraventricular Hypothalamic Nucleus/physiology , Stress, Psychological/physiopathology , Animals , Area Under Curve , Blood Pressure/physiology , Cobalt/pharmacology , Heart Rate/physiology , Male , Paraventricular Hypothalamic Nucleus/drug effects , Rats , Rats, Wistar , Restraint, Physical , Stress, Physiological , Synapses/drug effects , Synapses/physiology
8.
J Neurosci Res ; 86(14): 3203-11, 2008 Nov 01.
Article En | MEDLINE | ID: mdl-18543342

The lateral septal area (LSA) is a part of the limbic system and is involved in cardiovascular modulation. We previously reported that microinjection of noradrenaline (NA) into the LSA of unanesthetized rats caused pressor responses that are mediated by acute vasopressin release. Magnocellular neurons of the paraventricular (PVN) and supraoptic (SON) of the hypothalamus synthesize vasopressin. In the present work, we studied which of these nuclei is involved in the pressor pathway activated by unilateral NA injection into the LSA as well as the local neurotransmitter involved. Chemical ablation of the SON by unilateral injection of the nonspecific synapses blocker cobalt chloride (1 mM/100 nl) did not affect the pressor response evoked by NA (21 nmol/200 nl) microinjection into the LSA. However, the response to NA was blocked when cobalt chloride (1 mM/100 nl) was microinjected into the PVN, indicating that this hypothalamic nucleus is responsible for the mediation of the pressor response. There is evidence in the literature pointing to glutamate as a putative neurotransmitter activating magnocellular neurons. Pretreatment of the PVN with the selective non-N-methyl-D-asparate (NMDA) antagonist NBQX (2 nmol/100 nl) blocked the pressor response to NA microinjected into the LSA, whereas pretreatment with the selective NMDA antagonist LY235959 (2 nmol/100 nl) did not affect the response to NA. Our results implicate the PVN as the final structure in the pressor pathway activated by the microinjection of NA into the LSA. They also indicate that local glutamatergic synapses and non-NMDA glutamatergic receptors mediate the response in the PVN.


Cardiovascular Physiological Phenomena , Limbic System/drug effects , Norepinephrine/administration & dosage , Paraventricular Hypothalamic Nucleus/metabolism , Receptors, Glutamate/metabolism , Animals , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Glutamic Acid/metabolism , Injections, Intraventricular , Male , Microinjections , N-Methylaspartate/metabolism , Rats , Rats, Wistar , Vasopressins/metabolism
9.
Neurosci Lett ; 430(2): 124-9, 2008 Jan 10.
Article En | MEDLINE | ID: mdl-18035492

Microinjection of l-glutamate (l-glu: 1, 3, 10 and 30nmol/100nL) into the lateral hypothalamus (LH) caused dose-related depressor and bradycardiac responses. The cardiovascular response to l-glu stimulation of the LH was blocked by pretreatment of the ventrolateral portion of the periaqueductal gray matter (vlPAG) with CoCl2 (1mM/100nL), indicating the existence of a synaptic relay of the hypotensive pathway in that area. Furthermore, the response to l-glu was blocked by pretreatment of the vlPAG with 2nmol/100nL of the selective NMDA-receptor antagonist LY235959 and was not affected by pretreatment with 2nmol/100nL of the selective non-NMDA-receptor antagonist NBQX, suggesting a mediation of the hypotensive response by NMDA receptors in the vlPAG. In conclusion, our results indicate that the hypotensive pathway activated by microinjection of l-glu into the LH involves a NMDA synaptic relay in the vlPAG.


Blood Pressure/drug effects , Glutamic Acid/pharmacology , Heart Rate/drug effects , Hypothalamic Area, Lateral/drug effects , Periaqueductal Gray/physiology , Anesthesia , Animals , Cobalt/pharmacology , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , Isoquinolines/pharmacology , Male , Microinjections/methods , Nerve Block/instrumentation , Periaqueductal Gray/drug effects , Quinoxalines/pharmacology , Rats , Rats, Wistar
10.
J Neurosci Res ; 86(3): 712-9, 2008 Feb 15.
Article En | MEDLINE | ID: mdl-17893924

The periaqueductal gray area (PAG) is a mesencephalic area involved in cardiovascular modulation. Noradrenaline (NA), a neurotransmitter involved in central blood pressure control, is present in the rat PAG. We report here on the cardiovascular effects caused by NA microinjection into the ventrolateral PAG (vlPAG) of unanesthetized rats and the peripheral mechanism involved in their mediation. NA microinjection in the vlPAG of unanesthetized rats evoked dose-related pressor and bradycardiac responses. No significant cardiovascular responses were observed in urethane-anesthetized rats. The pressor response was potentiated by pretreatment with the ganglion blocker pentolinium (5 or 10 mg/kg, intravenously). Pretreatment with the vasopressin antagonist dTyr(CH2)5 (Me)AVP (50 microg/kg, intravenously) blocked the pressor response evoked by the NA microinjection into the vlPAG. Additionally, circulating vasopressin content was found to be significantly increased after NA microinjection in the vlPAG. The results suggest that activation of noradrenergic synapses within the vlPAG modulates vasopressin release in unanesthetized rats.


Cardiovascular System/drug effects , Norepinephrine/administration & dosage , Periaqueductal Gray , Vasoconstrictor Agents/administration & dosage , Anesthetics, Intravenous , Animals , Arginine Vasopressin/administration & dosage , Arginine Vasopressin/analogs & derivatives , Arginine Vasopressin/pharmacology , Blood Pressure/drug effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Synergism , Ganglionic Blockers/administration & dosage , Ganglionic Blockers/pharmacology , Heart Rate/drug effects , Hormone Antagonists/administration & dosage , Hormone Antagonists/pharmacology , Injections, Intravenous , Male , Microinjections , Norepinephrine/antagonists & inhibitors , Norepinephrine/pharmacology , Pentolinium Tartrate/administration & dosage , Pentolinium Tartrate/pharmacology , Rats , Rats, Wistar , Urethane , Vasoconstrictor Agents/antagonists & inhibitors , Vasoconstrictor Agents/pharmacology , Vasopressins/antagonists & inhibitors , Vasopressins/blood
11.
Neurosci Lett ; 426(2): 101-5, 2007 Oct 16.
Article En | MEDLINE | ID: mdl-17890005

The medial prefrontal cortex (MPFC) is a structure that is also involved in cardiovascular modulation. The injection of norepinephrine (NE) into the prelimbic (PL) area of the MPFC of unanesthetized rats evokes a pressor response which is mediated by acute vasopressin release. Vasopressin is synthesized by magnocellular cells of the paraventricular (PVN) and supraoptic nucleus (SON) of the hypothalamus. In the present study, we endeavored to determine which vasopressin-synthesizing hypothalamic nucleus is involved in the pressor pathway activated after NE injection into the PL area of the MPFC. We report here that lidocaine microinjection into the SON did not change the pressor response evoked by NE injection into the PL. However, the response to NE was blocked by prior injection of lidocaine or CoCl(2) into the PVN, indicating that this area is responsible for the mediation of this pressor response. A neuroanatomic experiment in which the neuronal tracer biotinylated dextran amine (BDA) was microinjected into the MPFC showed a lack of axons or neuronal cell bodies in the PVN, indicating that there are no direct connections between the PL area of the MPFC and the PVN. The results suggest that the PVN is involved in the mediation of the pressor response to NE in the PL area and that this pathway must relay in other brain structures before reaching the PVN.


Blood Pressure/drug effects , Norepinephrine/pharmacology , Paraventricular Hypothalamic Nucleus/physiology , Prefrontal Cortex/drug effects , Sympathomimetics/pharmacology , Wakefulness , Anesthetics, Local/pharmacology , Animals , Antimutagenic Agents/pharmacology , Blood Pressure/physiology , Cobalt/pharmacology , Drug Interactions , Lidocaine/pharmacology , Male , Neural Pathways/drug effects , Neural Pathways/physiology , Paraventricular Hypothalamic Nucleus/drug effects , Paraventricular Hypothalamic Nucleus/metabolism , Prefrontal Cortex/physiology , Rats , Rats, Wistar , Vasopressins/metabolism
12.
Life Sci ; 81(10): 855-62, 2007 Aug 16.
Article En | MEDLINE | ID: mdl-17761199

In a previous study, we reported depressor and bradycardiac responses after L-glutamate (L-glu) microinjection into the diagonal band of Broca (dbB) in anesthetized rats. Here, we report the glutamatergic-receptor subtype mediating the cardiovascular effects evoked by L-glu injection into the dbB and the involvement of local nitric oxide (NO) mechanisms as well as peripheral effectors. Microinjections of 100 nL of L-glu (1, 27, 81, 130 or 200 nmol) into the dbB of urethane-anesthetized rats caused short-lasting depressor and bradycardiac responses. Responses were dose-related, with an ED(50) of approximately 81 nmol. This dose was used in later experiments. The cardiovascular responses to L-glu in the dbB were abolished by local pretreatment (100 nL) with the selective N-methyl-D-aspartic acid (NMDA) receptor antagonist LY235959 (4 nmol) but were not affected by pretreatment with the selective non-NMDA receptor antagonist NBQX (4 nmol). Responses to L-glu in the dbB were blocked by local pretreatment with the selective neuronal NO-synthase (nNOS) inhibitor N(omega)-propyl-L-arginine (NPLA, 0.04 nmol); the NO scavenger carboxy-PTIO (C-PTIO, 1 nmol) or the guanylate cyclase inhibitor ODQ (1 nmol). These results suggest that the microinjection of L-glu into the dbB of urethane-anesthetized rats causes dose-related depressor and bradycardiac responses through the NMDA receptor-NO-guanylate cyclase pathway.


Blood Pressure/drug effects , Diagonal Band of Broca/drug effects , Glutamic Acid/administration & dosage , Heart Rate/drug effects , Nitrergic Neurons/drug effects , Receptors, Glutamate/drug effects , Anesthesia , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Benzoates/pharmacology , Blood Pressure/physiology , Dose-Response Relationship, Drug , Heart Rate/physiology , Imidazoles/pharmacology , Isoquinolines/pharmacology , Male , Microinjections/methods , Nitrergic Neurons/metabolism , Oxadiazoles/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar , Receptors, Glutamate/physiology
13.
Auton Neurosci ; 122(1-2): 84-93, 2005 Oct 30.
Article En | MEDLINE | ID: mdl-16199207

The lateral hypothalamus (LH) is involved in cardiovascular control. L-glutamate (L-glu) stimulation of the LH of unanesthetized rats evoked hypotensive responses without significant heart rate changes. The neuronal pathway that mediates this response is unknown. There is evidence that the periaqueductal gray (PAG) is involved in the mediation of hypotensive responses evoked by electrical stimulation of the LH. In the present study, we attempted to verify the effect of an acute and reversible pharmacological ablation of the PAG with lidocaine or CoCl(2) on the hypotensive response caused by L-glu injection in the LH of unanesthetized rats. Microinjection of the local anesthetic lidocaine or the unspecific synaptic blocker CoCl(2) in the PAG significantly attenuated the hypotensive effects of L-glu stimulation of the LH, indicating the involvement of local synapses within the PAG in the hypotensive pathway activated by LH glutamatergic receptors. Microinjection of the neuronal tracer biotinylated dextran amine (BDA) in the PAG labeled neuronal cell bodies in the LH, indicating the existence of direct connections between these areas. In conclusion, the present results indicate that the hypotensive response evoked by L-glu stimulation of LH may involve a synaptic relay in the dorsal PAG.


Glutamic Acid/administration & dosage , Hypothalamus/metabolism , Neural Pathways/cytology , Periaqueductal Gray/metabolism , Animals , Anti-Arrhythmia Agents/pharmacology , Cobalt/pharmacology , Hypotension/chemically induced , Hypotension/physiopathology , Hypothalamus/drug effects , Injections, Intraventricular , Lidocaine/pharmacology , Male , Microinjections , Neurons/cytology , Periaqueductal Gray/drug effects , Rats , Rats, Wistar
14.
J Neurosci Res ; 77(4): 613-20, 2004 Aug 15.
Article En | MEDLINE | ID: mdl-15264231

The medial prefrontal cortex (MPFC) is involved in central nervous system (CNS)-mediated cardiovascular modulation. We compared the cardiovascular effects of electrical stimulation (EE) of the MPFC in unanesthetized rats to those observed after stimulation of the same area in urethane-anesthetized rats. Electrical stimulation (35, 106, 177, 247, 318, and 389 microA rms/10 sec, 60-Hz sine wave) of the MPFC of urethane-anesthetized rats caused depressor responses of stimulus-related intensity. The cardiovascular response to electrical stimulation of the MPFC in unanesthetized rats was characterized by stimulus-related pressor responses. No significant heart rate changes were observed during the EE period in any case. The pressor response to electrical stimulation (106 microA rms/10 sec, 60-Hz sine wave) of the MPFC was not affected by intravenous pretreatment with the vasopressin antagonist dTyr(CH(2))(5)(Me)AVP (50 microg/kg, intravenously), by hypophysectomy, or by intravenous pretreatment with the angiotensin II antagonist losartan (1 mg/kg, intravenously). The pressor response was blocked by intravenous pretreatment with the ganglionic blocker mecamylamine (2 mg/kg, intravenously) but was not affected by adrenal demedullation, thus suggesting involvement of the neural component of the sympathetic nervous system without a major involvement of its hormonal component. Our results confirmed the occurrence of depressor responses after electrical stimulation of the MPFC in urethane-anesthetized rats and evidenced that only pressor responses are observed after its stimulation in unanesthetized rats. The fact that the pressor response to the stimulation of the MPFC was blocked by a ganglioplegic suggests that the MPFC has functional excitatory actions over the sympathetic nervous system.


Autonomic Pathways/physiology , Blood Pressure/physiology , Efferent Pathways/physiology , Prefrontal Cortex/physiology , Sympathetic Nervous System/physiology , Vasoconstriction/physiology , Adrenal Medulla/injuries , Adrenal Medulla/innervation , Adrenal Medulla/physiology , Angiotensin II/antagonists & inhibitors , Angiotensin II/metabolism , Animals , Autonomic Pathways/drug effects , Blood Pressure/drug effects , Denervation , Efferent Pathways/drug effects , Electric Stimulation , Electrodes, Implanted , Ganglia, Sympathetic/drug effects , Ganglia, Sympathetic/physiology , Losartan/pharmacology , Male , Mecamylamine/pharmacology , Prefrontal Cortex/cytology , Prefrontal Cortex/drug effects , Rats , Rats, Wistar , Sympathetic Nervous System/drug effects , Urethane/pharmacology , Vasoconstriction/drug effects , Vasopressins/antagonists & inhibitors , Wakefulness/physiology
15.
Brain Res ; 959(2): 312-9, 2003 Jan 10.
Article En | MEDLINE | ID: mdl-12493620

The diagonal band of Broca (dbB) is involved in central cardiovascular control. In the present study we compared the effects of microinjections of L-glutamate into the dbB of unanesthetized rats with those observed after the injection of L-glutamate into the same area in urethane-anesthetized rats. The microinjection of L-glutamate (10, 30, 100 or 200 nmol/200 nl) into the dbB of urethane-anesthetized rats caused dose-related short-lasting depressor responses The depressor responses to L-glutamate were accompanied by dose-related heart rate reduction. The cardiovascular response to the injection of L-glutamate (10, 30 or 100 nmol/200 nl) into the dbB of unanesthetized rats was characterized as a long-lasting pressor response without consistent heart rate changes. The pressor response was dose-related and presented an ED(50) of approximately 30 nmol/200 nl. The fact that the chemical stimulation of the dbB with L-glutamate caused only dose-related pressor responses in unanesthetized rats suggests that under normal conditions the dbB is predominantly a pressor area. After the characterization of the pressor response to L-glutamate microinjected into the dbB of unanesthetized rats we studied the mechanisms involved in the mediation of these responses. The pressor response to L-glutamate (30 nmol/200 nl) into the dbB was blocked by intravenous pretreatment with the vasopressin antagonist dTyr(CH(2))(5)(Me)AVP (50 microg/kg), suggesting the involvement of circulating vasopressin in this response. Further evidence of the involvement of the endocrine vasopressin system in the pressor response to L-glutamate injected into the dbB was provided by hypophysectomy since L-glutamate (30 nmol/200 nl) microinjection into the dbB of hypophysectomized rats caused only depressor responses. We presently report that chemical stimulation of the dbB with L-glutamate caused only pressor responses in unanesthetized rats that were mediated by vasopressin release into the systemic circulation. Additionally, the results confirmed the existence of an L-glutamate-sensitive depressor system in the dbB, which is predominant in urethane-anesthetized rats or may be evidenced in unanesthetized hypophysectomized rats.


Blood Pressure/drug effects , Diagonal Band of Broca/drug effects , Glutamic Acid/administration & dosage , Wakefulness/physiology , Animals , Blood Pressure/physiology , Diagonal Band of Broca/physiology , Dose-Response Relationship, Drug , Heart Rate/drug effects , Heart Rate/physiology , Male , Microinjections/methods , Pressoreceptors/drug effects , Pressoreceptors/physiology , Rats , Rats, Wistar
...